John Wen-Cheng Chang Selected Research

John Wen-Cheng Chang Research Topics

Disease

26	Neoplasms (Cancer) 02/2022 - 09/2003
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 12/2007
6	Melanoma (Melanoma, Malignant) 10/2020 - 09/2003
5	Adenocarcinoma 07/2021 - 10/2002
4	Neoplasm Metastasis (Metastasis) 02/2022 - 12/2007
4	Adenocarcinoma of Lung 01/2022 - 08/2006
4	Renal Cell Carcinoma (Grawitz Tumor) 09/2012 - 01/2010
3	Lung Neoplasms (Lung Cancer) 03/2021 - 09/2008
3	Disease Progression 03/2021 - 06/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2017
3	Carcinoma (Carcinomatosis) 07/2018 - 12/2013
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2021 - 05/2020
2	Diarrhea 03/2021 - 12/2007
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 03/2016
2	Hypertension (High Blood Pressure) 11/2017 - 06/2011
2	Exanthema (Rash) 09/2012 - 12/2007
2	Necrosis 01/2010 - 08/2006
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Venous Thromboembolism 01/2021
1	Ischemic Stroke 01/2021
1	Hemorrhage 01/2021
1	Myocardial Infarction 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Chromosomal Instability (Chromosome Stability) 11/2020
1	Dementia (Dementias) 01/2020
1	Hepatitis 09/2019
1	Fibrosis (Cirrhosis) 09/2019
1	Lymphatic Metastasis 10/2018
1	Coronary Disease (Coronary Heart Disease) 11/2017
1	Pleural Effusion (Pleural Effusions) 10/2017
1	Sarcoma (Soft Tissue Sarcoma) 10/2016
1	Ascites 01/2016
1	Epistaxis (Nosebleed) 09/2012

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 04/2022 - 09/2008
8	Tyrosine Kinase InhibitorsIBA 02/2022 - 09/2008
6	Gemcitabine FDA Link 06/2021 - 11/2008
6	Cisplatin (Platino)FDA LinkGeneric 05/2020 - 12/2007
5	Immune Checkpoint InhibitorsIBA 10/2021 - 10/2019
4	AfatinibIBA 04/2022 - 07/2021
4	Gefitinib (Iressa)FDA Link 02/2022 - 08/2006
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2022 - 12/2007
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021 - 11/2017
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 10/2016
3	Proteins (Proteins, Gene)FDA Link 10/2018 - 03/2015
3	Bevacizumab (Avastin)FDA Link 06/2011 - 06/2011
2	Alkaline PhosphataseIBA 06/2021 - 05/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 09/2015
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
2	AndrogensIBA 01/2020 - 11/2017
2	PlatinumIBA 04/2018 - 06/2011
2	Peptide Nucleic AcidsIBA 10/2017 - 10/2016
2	Sorafenib (BAY 43-9006)FDA Link 09/2012 - 01/2010
2	Pemetrexed (MTA)FDA Link 06/2011 - 06/2011
1	GSK2830371IBA 07/2021
1	siremadlinIBA 07/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2021
1	FluoroquinolonesIBA 04/2021
1	alectinibIBA 03/2021
1	CrizotinibIBA 03/2021
1	ceritinibIBA 03/2021
1	Anaplastic Lymphoma KinaseIBA 03/2021
1	AnticoagulantsIBA 01/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Vitamin K FDA Link 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021
1	N(4)-oleylcytosine arabinosideIBA 01/2021
1	AntibodiesIBA 10/2020
1	Metformin (Glucophage)FDA LinkGeneric 10/2020
1	Androgen Antagonists (Antiandrogens)IBA 01/2020
1	EnzymesIBA 09/2019
1	Alanine Transaminase (SGPT)IBA 09/2019
1	Transaminases (Aminotransferases)IBA 09/2019
1	Maraviroc FDA Link 10/2018
1	Small Interfering RNA (siRNA)IBA 10/2018
1	Formaldehyde (Formol)FDA Link 12/2016
1	ParaffinIBA 12/2016
1	Indicators and Reagents (Reagents)IBA 11/2016
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 03/2016
1	Dacarbazine (DIC)FDA LinkGeneric 12/2015
1	Interleukin-2 (IL2)IBA 12/2015
1	Complementary DNA (cDNA)IBA 09/2015
1	Parathyroid Hormone (Parathormone)IBA 03/2015
1	Everolimus FDA Link 09/2012

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 06/2021 - 10/2002
10	Therapeutics 07/2021 - 05/2010
2	Orchiectomy (Orchidectomy) 01/2020 - 11/2017
2	Chemoradiotherapy 07/2018 - 11/2017
2	Cystectomy 07/2018 - 11/2017
1	Adjuvant Chemotherapy 01/2021
1	Immunotherapy 10/2019
1	Terminal Care (Care, Terminal) 01/2019
1	Radiotherapy 07/2018
1	Castration 11/2017
1	Maintenance Chemotherapy 11/2017
1	Subcutaneous Injections 12/2015
1	Ligation 09/2015
1	Adjuvant Radiotherapy 12/2013